Viewing Study NCT01029366


Ignite Creation Date: 2025-12-24 @ 4:40 PM
Ignite Modification Date: 2026-02-07 @ 5:39 PM
Study NCT ID: NCT01029366
Status: COMPLETED
Last Update Posted: 2023-06-22
First Post: 2009-12-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: CART19 to Treat B-Cell Leukemia or Lymphoma That Are Resistant or Refractory to Chemotherapy
Sponsor: University of Pennsylvania
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hematopoietic/Lymphoid Cancer View
None Adult Acute Lymphoblastic Leukemia in Remission View
None B-cell Adult Acute Lymphoblastic Leukemia View
None B-cell Chronic Lymphocytic Leukemia View
None Prolymphocytic Leukemia View
None Recurrent Adult Diffuse Large Cell Lymphoma View
None Recurrent Grade 1 Follicular Lymphoma View
None Recurrent Grade 2 Follicular Lymphoma View
None Recurrent Grade 3 Follicular Lymphoma View
None Recurrent Mantle Cell Lymphoma View
None Refractory Chronic Lymphocytic Leukemia View
None Stage III Adult Diffuse Large Cell Lymphoma View
None Stage III Chronic Lymphocytic Leukemia View
None Stage III Grade 1 Follicular Lymphoma View
None Stage III Grade 2 Follicular Lymphoma View
None Stage III Grade 3 Follicular Lymphoma View
None Stage III Mantle Cell Lymphoma View
None Stage IV Adult Diffuse Large Cell Lymphoma View
None Stage IV Chronic Lymphocytic Leukemia View
None Stage IV Grade 1 Follicular Lymphoma View
None Stage IV Grade 2 Follicular Lymphoma View
None Stage IV Grade 3 Follicular Lymphoma View
None Stage IV Mantle Cell Lymphoma View
Keywords: